Text Size

A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

This study has been completed.
Sponsor:
Collaborators:
GlaxoSmithKline
United States Agency for International Development (USAID)
Walter Reed Army Institute of Research (WRAIR)
Kenya Medical Research Institute (KEMRI)
Information provided by:
U.S. Army Medical Research and Materiel Command
ClinicalTrials.gov Identifier:
NCT00666380
First received: April 22, 2008
Last updated: March 22, 2012
Last verified: March 2012
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
No publications provided by U.S. Army Medical Research and Materiel Command

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):